LYB LyondellBasell Industries N.V.
Industrial Organic Chemicals · NYSE · SEC CIK 1489393 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY3.5%
TTM net income YoY208.4%
TTM EPS YoY206.1%
Revenue 3-yr CAGR-8.2%
Net income 3-yr CAGR-17.1%
Margins
Gross margin14.3%
Operating margin8.6%
Net margin4.1%
FCF margin7.6%
EBITDA margin13.2%
Returns
ROE11.9%
ROA3.8%
ROIC (approx.)10.8%
Asset turnover0.93x
Leverage & solvency
Liabilities / assets67.3%
Debt / equity1.02x
Current ratio1.78x
Interest coverage5.06x
Cash quality & payout
Operating cash flow / net income2.85x
Accruals ratio-7.0%
Payout ratio85.6%
Capex / revenue4.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q3*2026-09-30 | 2026Q2*2026-06-30 | 2026Q1*2026-03-31 | 2025Q4*2025-12-31 | 2025Q3*2025-09-30 | 2025Q2*2025-06-30 | 2025Q1*2025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $8.50B | $9.18B | $7.20B | $7.09B | $7.73B | $7.66B | $7.68B | $7.81B |
| Cost of revenue | $7.00B | $7.14B | $6.50B | $6.76B | $6.82B | $6.87B | $7.13B | $7.00B |
| Gross profit | $1.50B | $2.04B | $701.00M | $335.00M | $906.00M | $787.00M | $549.00M | $805.00M |
| R&D expense | $35.00M | $34.00M | $36.00M | $33.00M | $34.00M | $35.00M | $34.00M | $39.00M |
| SG&A expense | $394.00M | $387.00M | $411.00M | $373.00M | $401.00M | $435.00M | $401.00M | $419.00M |
| Operating income | $1.07B | $1.54B | $239.00M | -$88.00M | -$731.00M | $285.00M | $114.00M | -$597.00M |
| Interest expense | $138.00M | $138.00M | $138.00M | $132.00M | $130.00M | $118.00M | $107.00M | $116.00M |
| Pretax income | $963.00M | $808.00M | $137.00M | -$142.00M | -$856.00M | $224.00M | $59.00M | -$818.00M |
| Income tax | $187.00M | $236.00M | -$2.00M | -$8.00M | -$27.00M | $69.00M | $36.00M | -$255.00M |
| Net income | $758.00M | $559.00M | $125.00M | -$140.00M | -$890.00M | $115.00M | $177.00M | -$603.00M |
| EBITDA | $1.44B | $1.89B | $581.00M | $297.00M | -$381.00M | $617.00M | $437.00M | -$208.00M |
| EPS (basic) | 2.32 | 1.71 | 0.38 | — | -2.77 | 0.34 | 0.54 | — |
| EPS (diluted) | 2.32 | 1.71 | 0.38 | — | -2.77 | 0.34 | 0.54 | — |
| Dividends declared per share | 0.69 | 0.69 | 0.69 | 1.37 | 1.37 | 1.37 | 1.34 | 1.34 |
| Balance sheet | ||||||||
| Cash & equivalents | $3.23B | $2.63B | $2.63B | $3.44B | $1.80B | $1.70B | $1.87B | $3.39B |
| Short-term investments | $2.09B | $1.43B | $1.47B | $2.03B | $703.00M | $820.00M | $1.16B | $2.61B |
| Inventory | $4.07B | $4.08B | $3.63B | $3.53B | $4.41B | $4.57B | $4.93B | $4.66B |
| Current assets | $12.07B | $11.66B | $11.06B | $10.87B | $10.76B | $11.08B | $11.40B | $12.27B |
| PP&E, net | $15.71B | $15.69B | $15.70B | $15.83B | $15.70B | $15.73B | $15.34B | $15.07B |
| Goodwill | $704.00M | $705.00M | $705.00M | $708.00M | $708.00M | $1.68B | $1.60B | $1.56B |
| Intangibles | $366.00M | $394.00M | $417.00M | $450.00M | $453.00M | $572.00M | $580.00M | $577.00M |
| Total assets | $34.75B | $34.48B | $33.96B | $34.00B | $33.79B | $35.35B | $35.19B | $35.75B |
| Current liabilities | $6.79B | $7.11B | $7.19B | $6.13B | $6.85B | $6.24B | $6.24B | $6.71B |
| Short-term debt | $247.00M | $234.00M | $226.00M | $226.00M | $137.00M | $119.00M | $120.00M | $119.00M |
| Long-term debt | $11.19B | $11.21B | $11.23B | $12.12B | $10.64B | $11.21B | $10.61B | $10.53B |
| Total debt | $11.44B | $11.45B | $11.45B | $12.35B | $10.78B | $11.33B | $10.72B | $10.65B |
| Total liabilities | $23.37B | $23.69B | $23.79B | $23.80B | $23.06B | $23.32B | $22.85B | $23.16B |
| Shareholders' equity | $11.25B | $10.67B | $10.04B | $10.08B | $10.60B | $11.91B | $12.21B | $12.46B |
| Net debt | $8.21B | $8.82B | $8.82B | $8.91B | $8.98B | $9.63B | $8.86B | $7.26B |
| Shares outstanding | 323.20M | 323.00M | 322.77M | 322.08M | 321.83M | 321.63M | 322.95M | 323.89M |
| Cash flow statement | ||||||||
| Operating cash flow | $1.72B | $752.00M | -$269.00M | $1.51B | $983.00M | $351.00M | -$579.00M | $1.92B |
| Capital expenditure | $303.00M | $270.00M | $269.00M | $450.00M | $406.00M | $539.00M | $483.00M | $504.00M |
| Free cash flow | $1.41B | $482.00M | -$538.00M | $1.06B | $577.00M | -$188.00M | -$1.06B | $1.41B |
| Investing cash flow | -$312.00M | -$515.00M | -$279.00M | -$403.00M | -$439.00M | -$504.00M | -$430.00M | -$547.00M |
| Financing cash flow | -$805.00M | -$233.00M | -$236.00M | $539.00M | -$448.00M | -$51.00M | -$547.00M | -$518.00M |
| Depreciation & amortization | $370.00M | $347.00M | $342.00M | $385.00M | $350.00M | $332.00M | $323.00M | $389.00M |
| Stock-based compensation | $14.00M | $19.00M | $47.00M | $21.00M | $15.00M | $20.00M | $35.00M | $20.00M |
| Dividends paid | $224.00M | $224.00M | $224.00M | $443.00M | $443.00M | $445.00M | $433.00M | $437.00M |
| Share buybacks | $0 | $0 | $0 | $0 | $0 | $91.00M | $110.00M | $78.00M |
Free plan shows the latest 8 periods; Pro shows all 63 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.